RNU6-295P

Across TCGA pan-cancer cohorts, RNU6-295P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RNU6-295P data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher RNU6-295P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-295P expression acts as an unfavorable survival marker.

KICH, KIRC, and UCEC are the cancer types where RNU6-295P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Tertile	All	0.053	0.924	<.001	108	view →
KIRC	DFS	Tertile	III,IV	0.160	0.490	<.001	105	view →
UCEC	DFS	Tertile	II,III,IV	0.512	0.827	.007	96	view →
KIRP	OS	Tertile	All	0.161	0.904	<.001	81	view →
SKCM	DFS	Tertile	All	0.063	0.731	<.001	39	view →
BRCA	DFS	Tertile	III,IV	0.238	0.796	.007	36	view →
THYM	DFS	Tertile	All	0.091	0.884	<.001	36	view →
SARC	OS	Tertile	All	0.108	0.839	<.001	36	view →
STAD	OS	Tertile	II,III,IV	0.239	0.721	<.001	27	view →
LIHC	DFS	Tertile	III,IV	0.040	0.361	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RNU6-295P–KICH (DFS)

Open the KICH breakdown →